Lupin surges as its arm to acquire 100% stake in Southern Cross Pharma Pty

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 1114.30, up by 28.65 points or 2.64% from its previous closing of Rs. 1085.65 on the BSE. The scrip opened at Rs. 1088.00 and has touched a high and low of Rs. 1117.25 and Rs. 1081.10 respectively. So far 31236 shares were traded on the counter. The BSE group … Read more

CSIR-CDRI, Lucknow committed to support Pharma Cluster in Uttar Pradesh and tied up with UP-based Company for developing a new drug

CSIR CDRI Lucknow committed to support Pharma Cluster in Uttar Pradesh and tied up with UP based Company for developing a new drug

CSIR-CDRI, Lucknow is committed to support Pharma Cluster in Uttar Pradesh and has tied up with UP-based Marc Laboratories Pvt. Ltd., India, a young progressive enterprise with operating base in 13 other states. It has signed an agreement for the development of a synthetic compoundS-007-867 as modulator of blood coagulation cascade, in particular as inhibitor … Read more

Department of Pharmaceuticals has taken several measures to create suitable environment for development of domestic capacity in the pharma sector : Shri Gowda

Union Minister of Chemicals and Fertilizers  Shri. D.V. Sadananda Gowda  has said that his Department of Pharmaceuticals has taken several measures to create suitable environment for development of domestic capacity in the pharma sector . He said  Prime Minister Sh. Narendra Modi has recently said that ‘India’s Pharma Industry is an asset not just for … Read more

Strides Pharma Science’s arm enters into agreement with SUDA Pharma

Strides Pharma Science’s step-down wholly owned subsidiary — Strides Pharma Global Pte, Singapore has entered into an exclusive product development, licensing and supply agreement with SUDA Pharmaceuticals for its novel drug SUD-001H, an oral spray of sumatriptan to treat migraine headache for the US market. Execution of Strides’ generic product pipeline for the US is … Read more

Glenmark Pharma to launch phase 1 trial in solid tumors for GBR 1342

Glenmark Pharmaceuticals is planning to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a non-interventional human study utilizing a clinically validated CAN script platform. GBR 1342 is based on Glenmark’s proprietary BEAT platform and simultaneously targets CD38 and the … Read more

Glenmark Pharma launches Nourkrin in Russia

Glenmark Pharmaceuticals has launched of Nourkrin in Russia. Nourkrin is a globally renowned, clinically-proven proteoglycan replacement formula, for addressing one of the key underlying causes of hair loss in males and females. Nourkrin Woman and Nourkrin Man will be exclusively marketed in Russia by Glenmark Impex LLC, the Russian subsidiary of Glenmark Pharmaceuticals Ltd., under … Read more

Biocon features in top global pharma & biotech employers list 2018

Biocon has moved up in the Top 10 Global Biotech Employers ranking for 2018 and continues to be the only company from Asia to feature on the prestigious U.S.-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list, since its debut in 2012. Ranked at No. 7 amongst global pharma and biotech companies in 2018, … Read more

BREAKING NEWS:
Get 365-day plans under ₹2000 before price hike! IPL 2026: Vaibhav Sooryavanshi Leads in Sixes! Rajasthan Royals lose despite Sooryavanshi’s fiery innings: Key culprits!